IFP Advisors
PROF icon

IFP Advisors’s Profound Medical PROF Stock Holding History

IFP Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,200
Closed -$7.98K – 5367
2026
Q2 		$7.98K Hold
1,200
– – ﹤0.01% 3531
2026
Q1 		$7.78K Hold
1,200
– – ﹤0.01% 3286
2025
Q4 		$9.44K Hold
1,200
– – ﹤0.01% 3094
2025
Q3 		$5.87K Hold
1,200
– – ﹤0.01% 3151
2025
Q2 		$7.08K Buy
1,200
+1,000
+500% +$5.29K ﹤0.01% 3127
2025
Q1 		$1.16K Hold
200
– – ﹤0.01% 3300
2024
Q4 		$1.5K Hold
200
– – ﹤0.01% 3187
2024
Q3 		$1.59K Buy
+200
New +$1.81K ﹤0.01% 2977

Other funds holding PROF

RMC
Ring Mountain Capital Tiburon, California $245M AUM 48.62% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
PM
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

IFP Advisors's PROF Position: Q3 2026 in Review

IFP Advisors sold out of Profound Medical (PROF) in Q3 2026, closing a stake of 1,200 shares — an estimated $7.98K sold.

IFP Advisors first reported a position in PROF in Q3 2024 and held it in 8 quarters. The position peaked at $9.44K in Q4 2025. 4 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • IFP Advisors reported no remaining Profound Medical position as of Q3 2026 after selling out during the quarter.
  • IFP Advisors sold 1,200 Profound Medical shares in Q3 2026, an estimated $7.98K.
  • IFP Advisors first reported a position in Profound Medical in Q3 2024 and held it in 8 quarters.
  • IFP Advisors's Profound Medical position peaked at $9.44K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.